☆ 4.7 Article

Medium-Term Outcomes in COVID-19

JOURNAL OF CLINICAL MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Long-term cardiovascular outcomes of COVID-19

Yan Xie et al.

Summary: Individuals with COVID-19, even those who were not hospitalized during the acute phase of the infection, are at an increased long-term risk of various cardiovascular disorders. A study using national healthcare databases found that beyond the first 30 days after infection, individuals with COVID-19 have an elevated risk of developing cerebrovascular disorders, heart diseases, and other cardiovascular complications. The risk increases depending on the care setting during the acute phase.

NATURE MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Inappropriate sinus tachycardia in post-COVID-19 syndrome

Julia Aranyo et al.

Summary: Inappropriate sinus tachycardia (IST) is prevalent among patients with post-COVID-19 syndrome (PCS), and it may be explained by an imbalance in the cardiac autonomic nervous system and decreased parasympathetic activity.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Immunology

Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Nandan Gautam et al.

Summary: A study found that a significant proportion of severely ill COVID-19 patients still experience symptoms such as breathlessness, fatigue, pain, reduced mobility, depression, and decreased quality of life 4-7 months after disease onset, with symptomatic patients having more residual chest radiographic and LFT abnormalities.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Electrocardiographic findings at presentation and clinical outcome in patients with SARS-CoV-2 infection

Gaetano Antonio Lanza et al.

Summary: The study demonstrates that standard ECG can be helpful for initial risk stratification of patients admitted for SARS-CoV-2 infectious disease, with ECG variables significantly associated with mortality.

EUROPACE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity

Andrea Spini et al.

Summary: The COVID-19 pandemic has demonstrated clear gender differences in health outcomes, with men showing more severe symptoms and higher mortality rates due to age-related decline in sex hormone levels. Women may benefit more from COVID-19 vaccines, despite experiencing more frequent adverse effects. Ensuring a focus on gender-specific research is crucial to avoid inequalities in healthcare.

PHARMACOLOGICAL RESEARCH (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prolonged QT predicts prognosis in COVID-19

Zaki Akhtar et al.

Summary: Evidence suggests that QTc prolongation in COVID-19 patients is associated with poor outcomes, with deceased patients exhibiting significantly longer QTc intervals compared to survivors. Additionally, age, C-reactive protein levels, and prolonged QTc beyond certain limits were identified as predictors of mortality in this study.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study

Daniel Ayoubkhani et al.

Summary: Patients discharged from the hospital after COVID-19 were found to have increased rates of multiorgan dysfunction, with higher risk not only limited to the elderly but also varying across ethnic groups.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study

Sara Paris et al.

Summary: Among hospitalized patients with COVID-19, a history of atrial fibrillation is associated with a higher mortality rate and more in-hospital events, including new-onset atrial fibrillation, acute heart failure, and multiorgan failure. The increased risk of mortality remains significant after adjusting for variables related to COVID-19 severity and comorbidities.

EUROPACE (2021)

Add to Collection

Article Medicine, General & Internal

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study

Lixue Huang et al.

LANCET (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Long COVID in a prospective cohort of home-isolated patients

Bjorn Blomberg et al.

Summary: An analysis of patients with SARS-CoV-2 infections in Bergen, Norway, revealed that a high proportion of patients experienced long-term COVID symptoms at 6 months, even though they were relatively young and had only mild to moderate acute COVID-19 symptoms. This highlights the significance of infection control measures, such as vaccination.

NATURE MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prevalence of bradyarrhythmias needing pacing in COVID-19

Zaki Akhtar et al.

Summary: During the COVID-19 pandemic, the number of new pacemaker implants decreased compared to the previous year, with a stable proportion of high-degree AV block cases. There was no evidence of transient high-degree AV block in COVID-19 patients, suggesting that all clinically significant bradyarrhythmia should be treated by pacing according to usual protocols regardless of COVID status.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Male gender is a predictor of higher mortality in hospitalized adults with COVID-19

Ninh T. Nguyen et al.

Summary: This study analyzed the characteristics and outcomes of male compared to female adults with COVID-19 in US academic centers. Males with COVID-19 showed higher rates of hypertension, diabetes, renal failure, heart failure, and liver disease, while females were more likely to be obese and have chronic pulmonary disease. Male COVID-19 patients had higher in-hospital mortality rates, higher rates of respiratory intubation, and longer hospital stays compared to females.

PLOS ONE (2021)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 and the cardiovascular system

Ying-Ying Zheng et al.

NATURE REVIEWS CARDIOLOGY (2020)

Add to Collection

Article Virology

Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity

Jiaofeng Huang et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Guidance on Short-Term Management of Atrial Fibrillation in Coronavirus Disease 2019

Pattara Rattanawong et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Electrophysiology in the time of coronavirus: coping with the great wave

Jia Li et al.

EUROPACE (2020)

Add to Collection

Article Medicine, General & Internal

Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis

Nuria Farre et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection

Brody H. Foy et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

T-wave inversion as a manifestation of COVID-19 infection: a case series

Jorge Romero et al.

JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population

Xiao-jing Chen et al.

OPEN HEART (2019)

Add to Collection

Article Medicine, General & Internal

QT-Interval Duration and Mortality Rate Results From the Third National Health and Nutrition Examination Survey

Yiyi Zhang et al.

ARCHIVES OF INTERNAL MEDICINE (2011)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

A BEAUTIFUL lesson-ivabradine protects from ischaemia, but not from heart failure: through heart rate reduction or more?

Gerd Heusch

EUROPEAN HEART JOURNAL (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram Part IV: The ST Segment, T and U Waves, and the QT Interval A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology

Pentti M. Rautaharju et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.